KMT5A and breast cancer: Knocking down SETD8 by shRNAs in T24 and HT1197 cells, which exhibit relatively high levels of SETD8 (Figure 1c; Figure S1e, Supporting Information), resulted in a significant reduction of BC cell viability, colony formation, and tumor growth (Figure 1d–i; Figure S1f, Supporting Information).